December 26, 2023

Solana Dominated over 21% of Past Week Sales of NFTs

NFTs

NFTs

The NFT sales over the past week witnessed a remarkable decline, as they went down by 36.16% at the time of writing. 

Over the past seven days, the NFT sales amounted to more than $394.953 million, over $199.793 million of which were from the Bitcoin blockchain, around 50% down from the previous week. Out of the top 20 blockchains, Bitcoin still had the lion’s share of the NFT sales seven days ago, accounting for around 50% of the total sales. 

Meanwhile, Solana is still performing well, coming in second place in terms of NFT sales for weeks, accounting for over 21% of the total sales ($85.175 million), a 13.7% incline from the previous week. 

Most of the blockchains over the past week saw a decrease in sales except Arbitrum. Blockchains of Ethereum, Polygon, Arbitrum, Immutable X, and Mythos Chain followed Solana regarding the total sales over the past week, respectively. 

Most of the NFT collections witnessed a decrease in their sales, topped by $SATS BRC-20 NFTs and $RATS BRC-20 NFTs, However, NFT collections of $BIIS BRC-20 NFTs and Sentry Node License witnessed growth over the past week, 285.36% and 44.05%, respectively.

Regarding the NFT price floor, Bored Ape Yacht Club is still in second place in terms of the highest floor value at 26.2 ETH, following CryptoPunks, whose floor was just 55 ETH, according to data from nftpricefloor.com.

Last week, The most expensive NFT was FrxETHRedemptionTicket #33, which sold for more than $638 million. The following top expensive NFTs sold over the past seven days were sold from $329 million and downwards. 

Blur leads the NFT marketplaces, followed by OKX NFT Marketplace. Blur’s sales over the past week reached $119.56 million, while the sales on OKX were $84.91 million (-77.12%). 

Tags :
Author profile

Whether you want to learn about NFT, Blockchain, Web3.0, Metaverse, or any other emerging technologies, we have the vital resources that will enlighten and help you make an informed decision.